Sprintec
Product Images NDC 67296-0952

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sprintec (NDC 67296-0952). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Image (Image 1)

Sprintec oral contraceptive tablet blister card containing norgestimate and ethinyl estradiol, 0.250 mg/0.035 mg, in a 28-day supply. The card shows four rows of circles representing daily pills, with the first three weeks of pills shaded and the fourth week unshaded. Days of the week are labeled across the top, with dosing instructions to take all colored pills before the white pills. The label includes storage temperature guidance and a note that it is prescription only by RedPharm Drug.*

FDA Label Image

1 (Image 2)

A forest plot chart showing effect estimates (odds ratios or relative risks) with confidence intervals from various studies comparing ever use and current use of contraceptives. Studies listed include the NICHD Women’s Contraceptive Study, French E3N cohort Study, Shanghai Women’s Health Study, Nurses’ Health Study II, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The horizontal axis is labeled 'Effect Estimate (OR/RR)' with values ranging from -1.5 to 2.*

FDA Label Image

Norgestimate Structural Formula (Image 3)

Chemical structure diagram of Norgestimate, USP, depicted with carbon rings, bonds, and chemical groups labeled.*

FDA Label Image

Ethinyl Estradiol Structural Formaula (Image 4)

Chemical structure of Ethinyl Estradiol, USP, shown as a molecular diagram with labeled hydroxyl groups and a triple bond, representing the active ingredient in Sprintec by RedPharm Drug.*

FDA Label Image

Fewer-more Pregnancies Image (Image 5)

A vertical effectiveness chart ranking various contraceptive methods by pregnancy rates per 100 women per year. The chart ranges from fewer than 1 pregnancy (implants, injections, intrauterine devices, sterilization) at the top to 85 or more pregnancies (no birth control) at the bottom, with intermediate effectiveness categories for birth control pills, skin patches, hormonal vaginal rings, condoms, diaphragms, behavioral methods, spermicides, and withdrawal.*

FDA Label Image

Blister Image (Image 6)

Sprintec oral contraceptive blister pack showing 28-day supply with 21 active tablets and 7 inactive tablets. Active tablets contain norgestimate and ethinyl estradiol (0.250 mg / 0.035 mg). The pack is labeled for once daily use with days of the week marked from Sunday to Saturday. The labeler is RedPharm Drug.*

FDA Label Image

Image (Image 7)

Packaging label for Sprintec (norgestimate and ethinyl estradiol tablets USP) 0.250 mg/0.035 mg. The carton contains 6 blister cards with 28 tablets each, intended for a 28-day regimen. Label includes storage instructions and states that the product is manufactured by Teva Pharmaceuticals USA, Inc. The label features the Teva logo and a logo for Shaping Women's Health.*

FDA Label Image

Image (Image 8)

Packaging label for Sprintec tablets, containing norgestimate and ethinyl estradiol USP at a strength of 0.250 mg/0.035 mg. The box includes 6 blister cards with 28 tablets each, featuring a 28-day regimen. Labeler names include RedPharm Drug and TEVA. The label includes regulatory and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.